常见实验室指标与肺栓塞患者预后的研究进展
Research Progress of Common Laboratory Indicators and Prognosis of Patients with Pulmonary Embolism
DOI: 10.12677/ACM.2022.12101378, PDF,   
作者: 郑 伟, 张怡欣, 吕卓航, 吴占庆:青海大学附属医院急诊科,青海 西宁
关键词: 肺栓塞(PE)预后综述Pulmonary Embolism (PE) Prognosis Review
摘要: 肺栓塞(pulmonary embolism, PE)是一种严重的疾病,具有重大的全球性影响。其临床表现缺乏特异性,预后差异极大,因此为首次诊断的科室急诊科带来了巨大的挑战。对PE患者的预后评估是推动其治疗的关键,寻找新的预后因素是更准确地估计短期不良事件的核心问题。本文描述了急诊科常见实验室指标,如血钙、中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值、D-二聚体等对PE患者预后的影响,从而指导PE患者个体化治疗、提高PE患者生存率。
Abstract: Pulmonary embolism (PE) is a serious disease with significant global impact. Its clinical presenta-tion lacks specificity and prognosis is highly variable, thus posing a huge challenge to the emergen-cy department for first-time diagnosis. Prognostic assessment of PE patients is the key to promoting their treatment, and finding new prognostic factors is the core issue for more accurate estimation of short-term adverse events. This article describes the impact of common laboratory indicators in the emergency department on the prognosis of PE patients, such as serum calcium, neutrophil to lym-phocyte ratio, platelet to lymphocyte ratio, D-dimer and so on, to guide individualized treatment of PE patients, improve survival rate of PE patients.
文章引用:郑伟, 张怡欣, 吕卓航, 吴占庆. 常见实验室指标与肺栓塞患者预后的研究进展[J]. 临床医学进展, 2022, 12(10): 9528-9533. https://doi.org/10.12677/ACM.2022.12101378

参考文献

[1] 胡大一, 丁荣晶. “胸痛中心”建设中国专家共识[J]. 中华危重症医学杂志(电子版), 2011, 4(6): 381-393.
[2] Wong, C.C., Ng, A.C., Lau, J.K., et al. (2016) The Prognostic Impact of Chest Pain in 1306 Patients Presenting with Confirmed Acute Pulmonary Embolism. International Journal of Cardiology, 221, 794-799. [Google Scholar] [CrossRef] [PubMed]
[3] Settelmeier, S., Hochadel, M., Giannitsis, E., et al. (2021) Man-agement of Pulmonary Embolism: Results from the German Chest Pain Unit Registry. Cardiology, 146, 304-310. [Google Scholar] [CrossRef] [PubMed]
[4] Lefevre-Scelles, A., Jeanmaire, P., Freund, Y., et al. (2020) Investigation of Pulmonary Embolism in Patients with Chest Pain in the Emergency Department: A Retrospective Multicenter Study. European Journal of Emergency Medicine, 27, 357-361. [Google Scholar] [CrossRef
[5] 北京急诊医学学会血栓与止血分会. 中国急诊医师对静脉血栓栓塞症诊治的认知现状及分析[J]. 中华急诊医学杂志, 2020, 29(8): 1082-1086.
[6] Ota, M., Nakamura, M., Yamada, N., et al. (2002) Prognostic Significance of Early Diagnosis in Acute Pulmonary Thromboembolism with Circulatory Failure. Heart Vessels, 17, 7-11. [Google Scholar] [CrossRef] [PubMed]
[7] Søgaard, K.K., Schmidt, M., Pedersen, L., et al. (2014) 30-Year Mortality after Venous Thromboembolism: A Population-Based Cohort Study. Circulation, 130, 829-836. [Google Scholar] [CrossRef
[8] Davlouros, P., Xanthopoulou, I., Mparampoutis, N., et al. (2016) Role of Calcium in Platelet Activation: Novel Insights and Pharmacological Implications. Medicinal Chemistry, 12, 131-138. [Google Scholar] [CrossRef] [PubMed]
[9] Usta, B., Gozdemir, M., Turgut, F., et al. (2007) Does Hypocalcemia Trigger Pulmonary Embolism? Medical Hypotheses, 68, 464-465. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, X., Xiang, Y., Zhang, T., et al. (2020) Association be-tween Serum Calcium and Prognosis in Patients with Acute Pulmonary Embolism and the Optimization of Pulmonary Embolism Severity Index. Respiratory Research, 21, Article No. 298. [Google Scholar] [CrossRef] [PubMed]
[11] Murthi, M., Shaka, H., El-Amir, Z., et al. (2021) Association of Hypocalcemia with In-Hospital Mortality and Complications in Patients with Acute Pulmonary Embolism: Results from the 2017 Nationwide Inpatient Sample. BMC Pulmonary Medicine, 21, Article No. 410. [Google Scholar] [CrossRef] [PubMed]
[12] 乔优, 袁媛, 范俊平, 等. 急性肺栓塞溶栓治疗的短期预后影响因素: 病例对照研究[J]. 协和医学杂志, 2020, 11(2): 144-150.
[13] Levi, M., van der Poll, T. and Büller, H.R. (2004) Bidirectional Relation between Inflammation and Coagulation. Circulation, 109, 2698-2704. [Google Scholar] [CrossRef
[14] Oyaizu, T., Fung, S.Y., Shiozaki, A., et al. (2012) Src Tyrosine Kinase Inhibition Prevents Pulmonary Ischemia-Re- perfusion-Induced Acute Lung Injury. Intensive Care Medicine, 38, 894-905. [Google Scholar] [CrossRef] [PubMed]
[15] Phan, T., Brailovsky, Y., Fareed, J., et al. (2020) Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism. Clinical and Applied Thrombosis/Hemostasis, 26, 1-7. [Google Scholar] [CrossRef] [PubMed]
[16] Ozcan Cetin, E.H., Cetin, M.S., Canpolat, U., et al. (2017) Plate-let-to-Lymphocyte Ratio as a Novel Marker of In-Hospital and Long-Term Adverse Outcomes among Patients with Acute Pulmonary Embolism: A Single Center Large-Scale Study. Thrombosis Research, 150, 33-40. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, Q., Ma, J., Jiang, Z., et al. (2018) Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lym- phocyte Ratio in Acute Pulmonary Embolism: A Systematic Re-view and Meta-Analysis. International Angiology, 37, 4-11. [Google Scholar] [CrossRef
[18] Galliazzo, S., Nigro, O., Bertù, L., et al. (2018) Prognostic Role of Neutrophils to Lymphocytes Ratio in Patients with Acute Pulmonary Embolism: A Systematic Review and Me-ta-Analysis of the Literature. Internal and Emergency Medicine, 13, 603-608. [Google Scholar] [CrossRef] [PubMed]
[19] Aujesky, D., Roy, P.M., Guy, M., et al. (2006) Prognostic Value of D-Dimer in Patients with Pulmonary Embolism. Thrombosis and Haemostasis, 96, 478-482. [Google Scholar] [CrossRef
[20] Becattini, C., Lignani, A., Masotti, L., et al. (2012) D-Dimer for Risk Stratification in Patients with Acute Pulmonary Embolism. Journal of Thrombosis and Haemostasis, 33, 48-57. [Google Scholar] [CrossRef] [PubMed]
[21] Grau, E., Tenías, J.M., Soto, M.J., et al. (2007) D-Dimer Levels Correlate with Mortality in Patients with Acute Pulmonary Embolism: Findings from the RIETE Registry. Critical Care Medicine, 35, 1937-1941. [Google Scholar] [CrossRef
[22] Polo Friz, H., Buzzini, C., Orenti, A., et al. (2016) Prognostic Value of D-Dimer in Elderly Patients with Pulmonary Embolism. Journal of Thrombosis and Haemostasis, 42, 386-392. [Google Scholar] [CrossRef] [PubMed]
[23] Tanabe, Y., Obayashi, T., Yamamoto, T., et al. (2015) Predictive Value of Biomarkers for the Prognosis of Acute Pulmonary Embolism in Japanese Patients: Results of the Tokyo CCU Network Registry. Journal of Cardiology, 66, 460-465. [Google Scholar] [CrossRef] [PubMed]
[24] Geissenberger, F., Schwarz, F., Probst, M., et al. (2019) D-Dimer Predicts Disease Severity but Not Long-Term Prognosis in Acute Pulmonary Embolism. Clinical and Applied Throm-bosis/Hemostasis, 25, 1-7. [Google Scholar] [CrossRef] [PubMed]
[25] Stein, P.D., Janjua, M., Matta, F., et al. (2011) Prognostic Value of D-Dimer in Stable Patients with Pulmonary Embolism. Clinical and Applied Thrombosis/Hemostasis, 17, E183-E185. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, X., Zheng, L., Han, J., et al. (2021) Joint Analysis of D-Dimer, N-Terminal pro b-Type Natriuretic Peptide, and Cardiac Troponin I on Predicting Acute Pulmonary Embolism Relapse and Mortality. Scientific Reports, 11, Article No. 14909. [Google Scholar] [CrossRef] [PubMed]
[27] Kucher, N., Printzen, G., Doernhoefer, T., et al. (2003) Low Pro-Brain Natriuretic Peptide Levels Predict Benign Clinical Outcome in Acute Pulmonary Embolism. Circulation, 107, 1576-1578. [Google Scholar] [CrossRef
[28] Agterof, M.J., Schutgens, R.E., Snijder, R.J., et al. (2010) Out of Hospital Treatment of Acute Pulmonary Embolism in Patients with a Low NT-proBNP Level. Journal of Thrombosis and Haemostasis, 8, 1235-1241. [Google Scholar] [CrossRef] [PubMed]
[29] Ng, A.C., Yong, A.S., Chow, V., et al. (2013) Cardiac Troponin-T and the Prediction of Acute and Long-Term Mortality after Acute Pulmonary Embolism. International Jour-nal of Cardiology, 165, 126-133. [Google Scholar] [CrossRef] [PubMed]
[30] Bajaj, A., Rathor, P., Sehgal, V., et al. (2015) Prognostic Value of Biomarkers in Acute Non-Massive Pulmonary Embolism: A Systematic Review and Meta-Analysis. Lung, 193, 639-651. [Google Scholar] [CrossRef] [PubMed]
[31] Bajaj, A., Saleeb, M., Rathor, P., et al. (2015) Prognostic Value of Troponins in Acute Nonmassive Pulmonary Embolism: A Meta-Analysis. Heart Lung, 44, 327-334. [Google Scholar] [CrossRef] [PubMed]
[32] Barco, S., Mahmoudpour, S.H., Planquette, B., et al. (2019) Prognostic Value of Right Ventricular Dysfunction or Elevated Cardiac Biomarkers in Patients with Low-Risk Pulmo-nary Embolism: A Systematic Review and Meta-Analysis. European Heart Journal, 40, 902-910. [Google Scholar] [CrossRef] [PubMed]
[33] Becattini, C., Vedovati, M.C. and Agnelli, G. (2007) Prognostic Val-ue of Troponins in Acute Pulmonary Embolism: A Meta-Analysis. Circulation, 116, 427-433. [Google Scholar] [CrossRef
[34] Goel, H., Melot, J., Krinock, M.D., et al. (2020) Heart-Type Fatty Acid-Binding Protein: An Overlooked Cardiac Biomarker. Annals of Medicine, 52, 444-461. [Google Scholar] [CrossRef] [PubMed]
[35] Langer, M., Forkmann, M., Richter, U., et al. (2016) Heart-Type Fatty Acid-Binding Protein and Myocardial Creatine Kinase Enable Rapid Risk Stratification in Normoten-sive Patients with Pulmonary Embolism. Journal of Critical Care, 35, 174-179. [Google Scholar] [CrossRef] [PubMed]
[36] Qian, H.Y., Huang, J., Yang, Y.J., et al. (2016) Heart-Type Fatty Acid Binding Protein in the Assessment of Acute Pulmonary Embolism. The American Journal of the Medical Sciences, 352, 557-562. [Google Scholar] [CrossRef] [PubMed]
[37] Kaczyñska, A., Pelsers, M.M., Bochowicz, A., et al. (2006) Plasma Heart-Type Fatty Acid Binding Protein Is Superior to Troponin and Myoglobin for Rapid Risk Stratification in Acute Pulmonary Embolism. Clinica Chimica Acta, 371, 117-123. [Google Scholar] [CrossRef] [PubMed]
[38] Liu, M., Yuan, X., Qiu, X., et al. (2015) Prognostic Role of Heart-Type Fatty Acid Binding Protein in Pulmonary Embolism: A Meta-Analysis. Thrombosis Research, 135, 20-25. [Google Scholar] [CrossRef] [PubMed]
[39] Bajaj, A., Rathor, P., Sehgal, V., et al. (2015) Risk Stratifica-tion in Acute Pulmonary Embolism with Heart-Type Fatty Acid-Binding Protein: A Meta-Analysis. Journal of Critical Care, 30, 1151.e1151-1157. [Google Scholar] [CrossRef] [PubMed]